Combating MRSA: Researchers study community-associated strain
December 4, 2012 by Jennifer Sicking in Diseases, Conditions, Syndromes
The Caenorhabditis elegans, a small worm called a nematode, scurrying across a Petri dish has helped lead to discoveries about community-associated MRSA (methicillin-resistant Staphylococcus aureus).
"In the last year this organism has killed more people in the United States than AIDS," said Kathleen Dannelly, an Indiana State University associate professor of biology leading the community-associated MRSA study. "It's going to get worse."
MRSA identifies a staph infection that is unable to be defeated by most penicillin-based drugs. Community-associated MRSA varies from the hospital-related one, which tends to be a more virulent strain picked up by people admitted to hospitals. Community-associated MRSA can cause toxic shock syndrome or blood and bone infections.
"They've picked up this incredible invasiveness mechanism that we don't understand at all," Dannelly said. "It's frightening what it can do."
A normal staph infection looks like a boil and remains in the skin. With MRSA, in the worst strains, the bacteria can eat down through the flesh to the bone in 36 hours.
Dannelly became interested in studying the community-associated MRSA in 2004 when an outbreak infected members of Indiana State University's football team. Players who received cuts and abrasions during games and practice found themselves diagnosed with MRSA and, in some cases, undergoing surgery for it.
Many people unknowingly carry MRSA on their skin as part of their bacteria and remain uninfected as long as they receive no cuts or scrapes to allow the bacteria to enter the body, Dannelly said. Six years ago, Dannelly and her students conducted a blind sidewalk study, swabbing the noses (MRSA thrives in warm, moist places) of 500 students, faculty and staff. They found that 1 ½ percent carried MRSA bacteria. Five years later, Dannelly and her researchers again conducted the blind study and they found the number of MRSA carriers had grown to 2 percent of the study group.
"The people had no idea they were carrying it," she said.
In the meantime, the scurrying nematode, which is only a few millimeters long, helped lead researchers to an interesting discovery. By comparing the genomes of community-associated MRSA and the staph infection, they found significant differences to investigate.
"This organism is so invasive we thought there have to be toxins that we don't know about," Dannelly said.
After cloning 15 genes, researchers have, thus far, purified six to determine what the proteins do. Researchers have found that MRSA's different proteins have unique functions such as sticking to human cells or interacting with white blood cells.
One project led researchers to a novel toxin that affects the nematode, which eats bacteria and has an immune system and nervous system in its body making it ideal for tests. They put the worm in the Petri dish with the toxin and watched.
"When you feed it the toxin it runs to the edge of the Petri dish to try to escape," Dannelly said. "This toxin kills the worm in eight minutes. It's really toxic."
Now researchers are testing the toxin on tissue cultures to see how it affects human cells.
As doctoral student Anupama Ramalinga worked in the lab among the tissue cultures, she said the toxin only seems to work on human cells, not on other mammals on which she tested it. She studied tissue cultures under the microscope and counted the number of cells so "in the test I know how many cells my protein killed," she said.
Research into MRSA's affect on humans and its proteins' roles remain important to figuring out the bacteria and how to stop its advance.
"If we don't know our enemy we can't defeat them. If we know our enemy, we can come up with new ways to defeat them," said Ramalinga, from Bangalore, India, who is researching the toxin's effect on tissue cultures. "This type of research will help us understand the bacteria, why it's becoming more robust, stronger."
While Ramalinga finishes her research and works with Dannelly to author a paper on the findings, some common practices can help people fight the bacteria. People can take steps against community-associated MRSA and good personal hygiene is the first step. Also, Dannelly said washing with antimicrobial soap and using a disinfectant in the nose can eliminate the microbes that cause the disease.
"You can disinfect a person and change their flora," she said.
Provided by
Indiana State University
-
Dangerous form of MRSA, endemic in many US hospitals, increasing in UK
Oct 23, 2012 |
not rated yet |
0
-
Scientists Find a New Toxin That May be Key to MRSA Severity
Jul 17, 2010 |
not rated yet |
0
-
Scientist warns of new MRSA threat
Feb 02, 2012 |
not rated yet |
0
-
Scientists battle against superbugs by targeting toxin released by virtually all strains of MRSA
Oct 13, 2011 |
not rated yet |
0
-
Where MRSA colonizes on the human body
Jan 05, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
FDA warns of infections tied to Tennessee pharmacy
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.
Diseases, Conditions, Syndromes
May 24, 2013 |
not rated yet |
0
Comorbidities common with alopecia areata
(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.
Diseases, Conditions, Syndromes
May 24, 2013 |
not rated yet |
0
Top-ranked golfer beats scoliosis
(HealthDay)—As a world-class golfer, Stacy Lewis' accomplishments are remarkable. But it was a physical challenge in her childhood that defined her ascent to the top of her sport.
Diseases, Conditions, Syndromes
May 24, 2013 |
not rated yet |
0
Saudi to send animal samples to US in coronavirus probe (Update)
Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.
Diseases, Conditions, Syndromes
May 24, 2013 |
not rated yet |
0
WHO voices deep concern over spread of SARS-like virus
The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.
Diseases, Conditions, Syndromes
May 24, 2013 |
5 / 5 (1) |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.